Reverse Vaccinology for Influenza A Virus: From Genome Sequencing to Vaccine Design
- 1 June 2023
- book chapter
- Published by Springer Nature
- Vol. 2673, 401-410
Abstract
Reverse vaccinology (RV) consists in the identification of potentially protective antigens expressed by any organism starting from genomic information and derived from in silico analysis, with the aim of promoting the discovery of new candidate vaccines against different types of pathogens. This approach makes use of bioinformatics techniques to screen the whole genomic sequence of a specific pathogen for the identification of the epitopes that could elicit the best immune response. The use of in silico techniques allows to reduce dramatically both the time and cost required for the identification of a potential vaccine, also facilitating the laborious process of selection of those antigens that, with a traditional approach, would be completely impossible to detect or culture. RV methodologies have been successfully applied for the identification of new vaccines against serogroup B meningococcus (MenB), Bacillus anthracis, Streptococcus pneumonia, Staphylococcus aureus, Chlamydia pneumoniae, Porphyromonas gingivalis, Edwardsiella tarda, and Mycobacterium tuberculosis. As a case of study, we will go in depth into the application of RV techniques on Influenza A virus. Key words Reverse vaccinology In silico trials Vaccine design Epitopes prediction Immune system response Immune system simulationKeywords
This publication has 17 references indexed in Scilit:
- Enhancing the Biological Relevance of Machine Learning Classifiers for Reverse VaccinologyInternational Journal of Molecular Sciences, 2017
- Immunomics: a 21st century approach to vaccine development for complex pathogensParasitology, 2016
- The promise of reverse vaccinologyInternational Health, 2015
- AllerTOP v.2—a server for in silico prediction of allergensJournal of Molecular Modeling, 2014
- Fast, scalable generation of high‐quality protein multiple sequence alignments using Clustal OmegaMolecular Systems Biology, 2011
- Large-scale validation of methods for cytotoxic T-lymphocyte epitope predictionBMC Bioinformatics, 2007
- VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccinesBMC Bioinformatics, 2007
- NERVE: New Enhanced Reverse Vaccinology EnvironmentBMC Biotechnology, 2006
- Two years into reverse vaccinologyVaccine, 2003
- Reverse vaccinologyCurrent Opinion in Microbiology, 2000